Pelthos Therapeutics Target Price

Analysts' average 12-month price target for Pelthos Therapeutics is $58.

Get informed when a big investor buys or sells

+ Follow

Share Price

$24.35

Average Target Price

$58.33

139.6% upside

3 analysts in the last 4 months

High: $66 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-14	OppenheimerJeff Jones	$64	162.8% upside
2026-08-13	Industrial Alliance Securities	$45	84.8% upside
2026-05-15	OppenheimerJeff Jones	$66	171% upside
2026-02-26	Roth Capital	$55	125.9% upside
2026-01-26	Oppenheimer	$60	146.4% upside
2025-12-03	Lake Street	$50	105.3% upside
2025-12-03	H.C. Wainwright	$60	146.4% upside
2025-11-25	Roth Capital	$57	134.1% upside
2025-09-02	UBS	$50	105.3% upside

Pelthos Therapeutics (PTHS) FAQ

Pelthos Therapeutics posts a target price of $58. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $58 for PTHS means covering analysts, on average, see the stock 139.6% upside of $24.35 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for PTHS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pelthos Therapeutics's other metric pages and overview cover the third.